Data / Federal awards / NAICS 325412 / Department of Justice
Department of Justice contracts under NAICS 325412 Pharmaceutical Preparation Manufacturing: $646.0 million to 58 recipients (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
Department of Justice obligated $646.0 million under NAICS 325412, Pharmaceutical Preparation Manufacturing, across 6,425 contract awards to 58 named recipients in fiscal years 2024 to 2027. The largest recipients are MCKESSON CORPORATION ($629.7 million), TAKEDA PHARMACEUTICALS AMERICA, INC. ($3.8 million), ACTELION PHARMACEUTICALS US, INC. ($2.3 million). 13 opportunities under this code are open on SAM.gov now.
The request: Every federal contract awarded by Department of Justice under NAICS 325412, with the winner, the value and the period of performance. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- Agency
- Department of Justice
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Contract awards
- 6,425
- Obligated
- $646.0 million
- Named recipients
- 58
- Small business share of obligations
- 0%
- Full and open competition share
- 98%
- Set aside share
- 0%
- Latest action
- 2026-09-30
Open opportunities in this niche
The same code on SAM.gov, read each morning: 13 opportunities you can still respond to.
Incumbents at this agency
Ranked by dollars obligated in fiscal years 2024 to 2027.
| Recipient | Business size | Awards | Obligated | Share |
|---|---|---|---|---|
| MCKESSON CORPORATION | Other Than Small Business | 5,636 | $629.7 million | 97.5% |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | Other Than Small Business | 28 | $3.8 million | 0.6% |
| ACTELION PHARMACEUTICALS US, INC. | Other Than Small Business | 59 | $2.3 million | 0.4% |
| PRIORITY HEALTHCARE DISTRIBUTION INC | Small Business | 53 | $2.1 million | 0.3% |
| SANOFI VACCINES US INC. | Other Than Small Business | 156 | $1.1 million | 0.2% |
| PETNET SOLUTIONS, INC. | Other Than Small Business | 5 | $895,507 | 0.1% |
| GLAXOSMITHKLINE, LLC | Other Than Small Business | 63 | $777,146 | 0.1% |
| BIOLOGICS, INC. | Other Than Small Business | 14 | $471,000 | 0.1% |
| SEQIRUS USA INC | Other Than Small Business | 117 | $407,919 | 0.1% |
| COVERMYMEDS PHARMACY LLC | Other Than Small Business | 3 | $385,512 | 0.1% |
| MCKESSON CORPORATION | Other Than Small Business | 4 | $385,256 | 0.1% |
| BAYER HEALTHCARE PHARMACEUTICALS INC | Other Than Small Business | 21 | $332,704 | 0.1% |
| ASD SPECIALTY HEALTHCARE, LLC | Other Than Small Business | 5 | $294,767 | 0.0% |
| DAIICHI SANKYO, INC | Other Than Small Business | 12 | $270,045 | 0.0% |
| KINIKSA PHARMACEUTICALS (UK), LTD. | Other Than Small Business | 6 | $268,695 | 0.0% |
| DIASOL INC | Small Business | 15 | $232,981 | 0.0% |
| MEDLINE INDUSTRIES, LP | Other Than Small Business | 6 | $199,711 | 0.0% |
| MOUNTAINSIDE MEDICAL EQUIPMENT INC | Small Business | 44 | $188,612 | 0.0% |
| VANTIVE US HEALTHCARE LLC | Other Than Small Business | 5 | $154,800 | 0.0% |
| PHAMATECH, INCORPORATED | Small Business | 63 | $149,412 | 0.0% |
| FRESENIUS USA, INC | Other Than Small Business | 7 | $142,461 | 0.0% |
| NATIONWIDE PHARMACEUTICAL LLC | Small Business | 1 | $126,554 | 0.0% |
| UNITED THERAPEUTICS CORP | Small Business | 5 | $117,857 | 0.0% |
| TAKEDA PHARMACEUTICALS AMERICA, INC | Other Than Small Business | 7 | $114,732 | 0.0% |
| BAXTER HEALTHCARE CORPORATION | Other Than Small Business | 3 | $114,327 | 0.0% |
| CAYMAN CHEMICAL CO INC | Other Than Small Business | 2 | $101,295 | 0.0% |
| VALNEVA USA, INC. | Other Than Small Business | 5 | $100,183 | 0.0% |
| MERCK SHARP & DOHME LLC | Other Than Small Business | 4 | $98,000 | 0.0% |
| PANTHERX SPECIALTY, LLC | Other Than Small Business | 4 | $80,828 | 0.0% |
| FOUNDATION CARE LLC | Other Than Small Business | 2 | $80,099 | 0.0% |
| VHG LABS INC | Other Than Small Business | 1 | $71,475 | 0.0% |
| HELSINN THERAPEUTICS (U.S.), INC. | Small Business | 8 | $47,877 | 0.0% |
| CARDINAL HEALTH 414, LLC | Other Than Small Business | 3 | $47,190 | 0.0% |
| NOVARTIS PHARMACEUTICALS CORPORATION | Other Than Small Business | 2 | $43,520 | 0.0% |
| SYMPHONY DIAGNOSTIC SERVICES NO. 1, LLC | Other Than Small Business | 3 | $40,370 | 0.0% |
| MERAKAI, LLC | Other Than Small Business | 3 | $40,065 | 0.0% |
| LEONARDO US CYBER AND SECURITY SOLUTIONS, LLC | Other Than Small Business | 2 | $39,072 | 0.0% |
| EXELAN PHARMACEUTICALS INC | Other Than Small Business | 5 | $31,835 | 0.0% |
| CVS HEALTH CORPORATION | Other Than Small Business | 1 | $29,074 | 0.0% |
| BRISTOL-MYERS SQUIBB COMPANY | Other Than Small Business | 2 | $22,639 | 0.0% |
| CONVERGINT TECHNOLOGIES LLC | Other Than Small Business | 1 | $20,718 | 0.0% |
| NATIONAL COMMISSION ON CORRECTIONAL HEALTH CARE | Other Than Small Business | 1 | $18,002 | 0.0% |
| EXPRESS SCRIPTS INC | Other Than Small Business | 1 | $16,835 | 0.0% |
| CARDINAL HEALTH 108, LLC | Other Than Small Business | 4 | $10,048 | 0.0% |
| CARDINAL HEALTH, INC. | Other Than Small Business | 1 | $6,050 | 0.0% |
| ACCREDO HEALTH GROUP, INC | Other Than Small Business | 2 | $4,089 | 0.0% |
| EMES2 PHARMACEUTICALS, LLC | Other Than Small Business | 2 | $4,080 | 0.0% |
| MCKESSON MEDICAL-SURGICAL GOVERNMENT SOLUTIONS LLC | Other Than Small Business | 2 | $2,842 | 0.0% |
| INDIVIOR INC. | Small Business | 2 | $2,654 | 0.0% |
| DYNAVAX TECHNOLOGIES CORPORATION | Small Business | 1 | $364 | 0.0% |
Offices buying
| Sub agency | Awards | Obligated |
|---|---|---|
| Federal Prison System / Bureau of Prisons | 6,347 | $644 million |
| Federal Bureau of Investigation | 20 | $1.3 million |
| Drug Enforcement Administration | 53 | $440,839 |
| U.S. Marshals Service | 5 | $199,636 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $228.2 million |
| FY2025 | $217.2 million |
| FY2026 | $200.6 million |
Products and services bought
| Code | Product or service | Awards | Obligated |
|---|---|---|---|
| 6505 | Drugs and Biologicals | 5,902 | $617.6 million |
| 3650 | Chemical and Pharmaceutical Products Manufacturing Machinery | 25 | $7.6 million |
| Q201 | Medical- Managed Healthcare | 103 | $7.1 million |
| Q517 | Medical- Pharmacology | 148 | $6.5 million |
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | 100 | $5.7 million |
| Q999 | Medical- Other | 39 | $497,514 |
| 6509 | Drugs and Biologicals, Veterinary Use | 3 | $325,714 |
| 8945 | Food, Oils and Fats | 1 | $205,935 |
Largest contract awards
| Award ID | Recipient | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 15B10625F00000042 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON NON-CONTROLLED DOS: NOV 1- CR MARCH 14, 2024 | $29,153,376 | $29,153,376 | January 3, 2025 | September 30, 2025 | Irving, TX | usaspending.gov |
| 15B10626F00000037 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025. | $24,534,880 | $24,534,880 | October 1, 2025 | August 9, 2026 | Irving, TX | usaspending.gov |
| 15B51924F00000095 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | PHARMACEUTICALS | $18,248,349 | $18,248,349 | June 18, 2024 | June 30, 2024 | Irving, TX | usaspending.gov |
| 15B51926F00000155 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | BIKTARVY #376-0550 6624 BOTTLES | $15,157,964 | $15,157,964 | September 25, 2026 | September 25, 2026 | Irving, TX | usaspending.gov |
| 15B51925F00000144 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | PHARMACEUTICALS | $12,881,289 | $12,881,289 | July 22, 2025 | August 5, 2025 | Irving, TX | usaspending.gov |
| 15B20525F00000011 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 25 PROCUREMENT OF PHARMACEUTICALS ON THE PPV | $5,306,603 | $5,306,603 | October 1, 2024 | September 30, 2025 | Irving, TX | usaspending.gov |
| 15B10626F00000172 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON: NON-CONTROLLED MEDICATION DOS: AUGUST 10, 2026- SEPTEMBER 30, 2026 | $5,000,000 | $5,000,000 | August 10, 2026 | September 30, 2026 | Irving, TX | usaspending.gov |
| 15B51925F00000177 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | PHARMACEUTICALS | $4,855,701 | $4,855,701 | August 28, 2025 | September 30, 2025 | Irving, TX | usaspending.gov |
| 15B50926F00000006 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON PHARMACEUTICALS FOR INMATES AT FMC FORT WORTH | $4,581,049 | $4,581,049 | December 31, 2025 | September 30, 2026 | Irving, TX | usaspending.gov |
| 15B51926F00000129 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | PHARMACEUTICALS | $4,460,593 | $4,460,593 | September 4, 2026 | September 4, 2026 | Irving, TX | usaspending.gov |
| 15B20524F00000009 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 24 PERIOD OF PERFORMANCE: FISCAL YEAR 24 FUNDED THROUGH CONTINUING RESOLUTION PERIOD: NOVEMBER 17TH, | $4,454,736 | $4,454,736 | October 1, 2023 | August 9, 2024 | Irving, TX | usaspending.gov |
| 15B50525F00000012 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON STANDARD MEDICATION FY 2025 | $4,450,242 | $4,450,242 | October 1, 2024 | September 30, 2025 | Irving, TX | usaspending.gov |
| 15B50524F00000012 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON STANDARD MEDICATION FY 2024 | $3,963,285 | $3,963,285 | October 1, 2023 | April 16, 2025 | Irving, TX | usaspending.gov |
| 15B51925F00000154 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | PHARMACEUTICALS | $3,800,114 | $3,800,114 | July 30, 2025 | August 29, 2025 | Irving, TX | usaspending.gov |
| 15B20526F00000003 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 26 | $3,464,920 | $3,464,920 | October 1, 2025 | December 31, 2025 | Irving, TX | usaspending.gov |
| 15B10625F00000005 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON NON-CONTROLLED $3,090,487.28 ADD FUNDS TO HEADER ACCOUNTING. | $3,090,596 | $3,090,596 | October 1, 2024 | October 31, 2024 | Irving, TX | usaspending.gov |
| 15B30224F00000020 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON MAT MEDICATIONS OCTOBER TO SEPTEMBER 2024 FISCAL YEAR 2024 FUND: 1060ADB / PROJECT: 90F RP#: 0053-24 | $2,852,553 | $2,852,553 | October 1, 2023 | September 30, 2024 | Irving, TX | usaspending.gov |
| 15B10624F00000001 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON NON-CONTROLED DRUGS INCLUDING HIV AND HEP. PERIOD OF PERFORMANCE: 10/01/2023 - 10/31/2023 IN ACCORDNACE WITH VA CONTRACT #36W79720D | $2,776,844 | $2,776,844 | October 1, 2023 | October 31, 2023 | Irving, TX | usaspending.gov |
| 15B10624F00000165 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON NON- CONTROLLED DRUGS INCLUDING HIV, HEP, AND SPECIALTY. DOS: APRIL 1 TO APRIL 30,2024 | $2,654,203 | $2,654,203 | April 1, 2024 | May 20, 2024 | Irving, TX | usaspending.gov |
| 15B10624F00000278 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON NON- CONTROLLED DRUGS INCLUDING HIV, HEP, AND SPECIALTY. DOS: SEPTEMBER 1 TO SEPTEMBER 30, 2024 | $2,640,242 | $2,640,242 | September 1, 2024 | September 30, 2024 | Irving, TX | usaspending.gov |
| 15B41824F00000013 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | REGULAR MEDICATION FY 24 FOR THE INMATE POPULATION | $2,620,225 | $2,620,225 | October 1, 2023 | September 30, 2024 | Irving, TX | usaspending.gov |
| 15B10624F00000220 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON NON- CONTROLLED DRUGS INCLUDING HIV, HEP, AND SPECIALTY. DOS: JUNE 1 TO JUNE 30, 2024 | $2,613,712 | $2,613,712 | June 1, 2024 | June 30, 2024 | Irving, TX | usaspending.gov |
| 15B10624F00000226 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON NON- CONTROLLED DRUGS INCLUDING HIV, HEP, AND SPECIALTY. DOS: JULY 1 TO JULY 31, 2024 | $2,608,724 | $2,608,724 | July 1, 2024 | July 31, 2024 | Irving, TX | usaspending.gov |
| 15B10624F00000208 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON NON- CONTROLLED DRUGS INCLUDING HIV, HEP, AND SPECIALTY. DOS: MAY 1 TO MAY 31, 2024 | $2,557,737 | $2,557,737 | May 1, 2024 | May 31, 2024 | Irving, TX | usaspending.gov |
| 15B10624F00000119 | MCKESSON CORPORATION | Department of Justice | Delivery Order | 325412 | MCKESSON NON- CONTROLLED DRUGS INCLUDING HIV, HEP, AND SPECIALTY. DOS: FEBRUARY 1 TO FEBRUARY 29, 2024 | $2,494,941 | $2,494,941 | February 1, 2024 | May 9, 2024 | Irving, TX | usaspending.gov |
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.